45
Views
5
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The Efficacy of Hyperbaric Oxygen for the Treatment of Experimental Uveitis Induced in Rabbits

, , , , , , & show all
Pages 383-388 | Accepted 03 Apr 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

S. Eperon, K. Balaskas, J. Vaudaux & Y. Guex-Crosier. (2013) Experimental Uveitis can be Maintained in Rabbits for a Period of Six Weeks After a Safe Sensitization Method. Current Eye Research 38:3, pages 405-412.
Read now

Articles from other publishers (4)

Kewal K. JainHeather Murphy-Lavoie, Tracy LeGros, Frank K. ButlerJr.Jr. & K. K. Jain. 2017. Textbook of Hyperbaric Medicine. Textbook of Hyperbaric Medicine 457 483 .
Günalp Uzun, Ali Ayata, Mesut Mutluoğlu, Şenol Yıldız & Dilaver Erşanlı. (2010) Can Hyperbaric Oxygen Therapy Turn off the Angiogenic Switch in Corneal Neovascularization?. Electronic Journal of General Medicine 7:1, pages 118-119.
Crossref
Hamid Hosseini, Akbar Safaei, Mohammad R. Khalili, Behdokht Nowroozizadeh, Masoometh Eghtedari, Mohsen Farvardin, Sarah Nowroozizadeh & Hamid R. Tolide-Ie. (2018) Intravitreal Infliximab in Experimental Endotoxin-Induced Uveitis. European Journal of Ophthalmology 19:5, pages 818-823.
Crossref
. (2006) Current World Literature. Current Opinion in Ophthalmology 17:6, pages 574-583.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.